Moderna’s COVID-19 Vaccine Spikevax Receives Full FDA Approval for Children Aged 6 Months to 11 Years at “Increased Risk”

by Jim Hᴏft, TGP The U.S. Food and Drug Administration (FDA) has officially granted full approval to Moderna’s controversial mRNA COVID-19 vaccine, Spikevax, for children as young as 6 months old…[...]

Read More

Impact of the COVID-19 pandemic and vaccination on global, regional, and national burden of Guillain-Barré syndrome: observational study

Xīn Gào, Chen Zhao, Junting Yang, Ziming Yang, et. al. ,doi: https://doi.org/10.1101/2024.07.09.24309613 Objectives To estimate the global, regional, and national burden and trends of Guillain-Barré Syndrome (GBS), and to explore the impact of the COVID-19 pandemic and related public health…[...]

Read More

SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review

Xiaohui Jing, Menglin Han, Xiaoxuan Wang & Li Zhou BMC Infectious Diseases volume 23, Article number: 577 (2023) Cite this article Update published on 02 October 2023 Abstract Background Corona Virus Disease 2019 (COVID-19) mRNA vaccine effectiveness (VE) has recently…[...]

Read More